Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1973 Jun;49(572):416–418.

Pyrimidine analogues in the treatment of experimental herpes infections

A H Tomlinson, F O MacCallum
PMCID: PMC2495872

Full text

PDF
416

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Clarkson D. R., Oppelt W. W., Byvoet P. The fate of 5-iodo-2'-deoxyuridine (IUdR) in plasma and cerebrospinal fluid of dogs. J Pharmacol Exp Ther. 1967 Sep;157(3):581–588. [PubMed] [Google Scholar]
  2. Jawetz E., Schultz R., Coleman V., Okumoto M. Studies on herpes simplex. XI. The antiviral dynamics of 5-iodo-2-deoxyuridine in vivo. J Immunol. 1965 Oct;95(4):635–642. [PubMed] [Google Scholar]
  3. KAUFMAN H. E. Clinical cure of herpes simplex keratitis by 5-iodo-2-deoxyuridine. Proc Soc Exp Biol Med. 1962 Feb;109:251–252. doi: 10.3181/00379727-109-27169. [DOI] [PubMed] [Google Scholar]
  4. KAUFMAN H. E., MALONEY E. D. IDU and cytosine arabinoside in experimental herpetic keratitis. Arch Ophthalmol. 1963 May;69:626–629. doi: 10.1001/archopht.1963.00960040632017. [DOI] [PubMed] [Google Scholar]
  5. Kurtz S. M., Fisken R. A., Kaump D. H., Schardn J. L. Toxicity of 9-beta-D-arabinofuranosyladenine in mice and rabbits. Antimicrob Agents Chemother (Bethesda) 1968;8:180–189. [PubMed] [Google Scholar]
  6. Miller F. A., Dixon G. J., Ehrlich J., Sloan B. J., McLean I. W., Jr Antiviral activity of 9-beta-D-arabinofuranosyladenine. I. Cell culture studies. Antimicrob Agents Chemother (Bethesda) 1968;8:136–147. [PubMed] [Google Scholar]
  7. PRIVATDEGARILHE M., DE RUDDER J. EFFET DE DEUX NUCL'EOSIDES DE L'ARABINOSE SUR LA MULTIPLICATION DES VIRUS DE L'HERP'ES ET DE LA VACCINE EN CULTURE CELLULAIRE. C R Hebd Seances Acad Sci. 1964 Oct 19;259:2725–2728. [PubMed] [Google Scholar]
  8. Renis H. E., Hollowell C. A., Underwood G. E. Nucleic acids. 3. Antiviral activity of nucleotides and dinucleoside phosphates containing ara-cytidine. J Med Chem. 1967 Sep;10(5):777–782. doi: 10.1021/jm00317a005. [DOI] [PubMed] [Google Scholar]
  9. Sidwell R. W., Dixon G. J., Schabel F. M., Jr, Kaump D. H. Antiviral activity of 9-beta-D-arabinofuranosyladenine. II. Activity against Herpes simplex keratitis in hamsters. Antimicrob Agents Chemother (Bethesda) 1968;8:148–154. [PubMed] [Google Scholar]
  10. Sloan B. J., Miller F. A., Ehrlich J., McLean I. W., Machamer H. E. Antiviral activity of 0-beta-D-arabinofuranosyladenine. IV. Activity against intracerebral herpes simplex virus infections in mice. Antimicrob Agents Chemother (Bethesda) 1968;8:161–171. [PubMed] [Google Scholar]
  11. Tokumaru T. The protective effect of different immunoglobulins against herpetic encephalitis and skin infection in guinea pigs. Arch Gesamte Virusforsch. 1967;22(3):332–348. doi: 10.1007/BF01242954. [DOI] [PubMed] [Google Scholar]
  12. Tomlinson A. H., Maccallum F. O. The effect of 5-iodo-2'-deoxyuridine on herpes simplex virus infections in guinea-pig skin. Br J Exp Pathol. 1968 Jun;49(3):277–282. [PMC free article] [PubMed] [Google Scholar]
  13. UNDERWOOD G. E. Activity of 1-beta-D-arabinofuranosylcytosine hydrochloride against herpes simplex keratitis. Proc Soc Exp Biol Med. 1962 Dec;111:660–664. doi: 10.3181/00379727-111-27884. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES